| 101.48 Data as of Jun 17 |  +0.34 / +0.34%Today’s Change | 81.28 Today|||52-Week Range 116.45 | +10.63% Year-to-Date |
| Whatbs Next For This Biotech? Jun 11 / MotleyFool.com | Acadia Pharmaceuticals Soars On Hedge Fund Investment Jun 10 / MotleyFool.com |
| 4 Stocks Boosting The Drugs Industry Higher Jun 11 / TheStreet.com |
| Previous close | 101.14 |
| Today’s open | 101.48 |
| Day’s range | 101.00 - 102.94 |
| Volume | 2,388,048 |
| Average volume (3 months) | 2,037,590 |
| Market cap | $30.1B |
| Dividend yield | 0.20% |
| Earnings growth (last year) | +18.94% |
| Earnings growth (this year) | +14.62% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | +8.58% |
| P/E ratio | 27.2 |
| Price/Sales | 4.76 |
| Price/Book | 5.22 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRXValeant Pharmaceutic... | +0.62 | +0.74% |
| SHPGShire PLC | +0.24 | +0.24% |
| ALXNAlexion Pharmaceutic... | -0.90 | -0.98% |
| VRTXVertex Pharmaceutica... | -1.56 | -1.94% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $5.8B |
| Annual profit (last year) | $1.1B |
| Net profit margin | 18.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer David E. I. Pyott, MBA |
Chief Financial Officer & EVP-Business Development Jeffrey L. Edwards |
Corporate headquarters Irvine, California |
.
